Pharmacist-Led Education Intervention for Adults With Allergic Rhinitis: A Randomized Clinical Trial.

ABSTRACT:

Importance

Allergic rhinitis (AR) affects 10% to 30% of the adult population globally. The current framework of pharmaceutical care for managing AR focuses on community pharmacies, with limited structured pharmaceutical care in public health care settings.

Objective

To evaluate the effectiveness of a pharmacist-led education intervention (AR-PRISE) in a public health care institution compared with standard care for managing AR among adults.

Design, setting, and participants

This randomized clinical trial used a 2-arm, parallel-group, open-label design in the otorhinolaryngology clinic of a government-funded tertiary referral hospital in northern Malaysia. Enrollment occurred from June 1, 2023, to February 15, 2024, with follow-up completed August 6, 2024. The trial in

SUBMITTER: Chew CC 

PROVIDER: S-EPMC12268493 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature